×
Entrez Id:
8701
Gene Symbol:
DNAH11
DNAH11
0.400
CausalMutation
phenotype
CLINVAR
×
Entrez Id:
55252
Gene Symbol:
ASXL2
ASXL2
0.100
CausalMutation
phenotype
CLINVAR
×
Entrez Id:
64324
Gene Symbol:
NSD1
NSD1
0.100
CausalMutation
phenotype
CLINVAR
×
Entrez Id:
5530
Gene Symbol:
PPP3CA
PPP3CA
0.100
CausalMutation
phenotype
CLINVAR
×
Entrez Id:
3952
Gene Symbol:
LEP
LEP
0.300
Therapeutic
phenotype
CTD_human
Synthesis and evaluation of diarylthiazole derivatives that inhibit activation of sterol regulatory element-binding proteins.
21561152
2011
×
Entrez Id:
3952
Gene Symbol:
LEP
LEP
0.300
Therapeutic
phenotype
CTD_human
A small molecule that blocks fat synthesis by inhibiting the activation of SREBP.
19716478
2009
×
Entrez Id:
5467
Gene Symbol:
PPARD
PPARD
0.300
Therapeutic
phenotype
CTD_human
Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta -dependent pathways.
20176998
2010
×
Entrez Id:
3952
Gene Symbol:
LEP
LEP
0.300
Therapeutic
phenotype
CTD_human
IL-33 Drives Augmented Responses to Ozone in Obese Mice.
27472835
2017
×
Entrez Id:
412
Gene Symbol:
STS
STS
0.300
Therapeutic
phenotype
CTD_human
Hepatic overexpression of steroid sulfatase ameliorates mouse models of obesity and type 2 diabetes through sex-specific mechanisms.
24497646
2014
×
Entrez Id:
3952
Gene Symbol:
LEP
LEP
0.300
Therapeutic
phenotype
CTD_human
Thus, variation in the leptin gene may be a risk factor for weight gain in male patients with schizophrenia on long-term clozapine treatment.
17502770
2007
×
Entrez Id:
29108
Gene Symbol:
PYCARD
PYCARD
0.300
Therapeutic
phenotype
CTD_human
Activation of inflammasomes in podocyte injury of mice on the high fat diet: Effects of ASC gene deletion and silencing.
24508291
2014
×
Entrez Id:
3952
Gene Symbol:
LEP
LEP
0.300
Therapeutic
phenotype
CTD_human
Role for fatty acid amide hydrolase (FAAH) in the leptin-mediated effects on feeding and energy balance.
29967158
2018
×
Entrez Id:
3952
Gene Symbol:
LEP
LEP
0.300
Therapeutic
phenotype
CTD_human
Oral administration of Nitraria retusa ethanolic extract enhances hepatic lipid metabolism in db/db mice model 'BKS.Cg-Dock7(m)+/+ Lepr(db/)J' through the modulation of lipogenesis-lipolysis balance.
25086370
2014
×
Entrez Id:
3952
Gene Symbol:
LEP
LEP
0.300
Therapeutic
phenotype
CTD_human
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults.
15070752
2004
×
Entrez Id:
3952
Gene Symbol:
LEP
LEP
0.300
Therapeutic
phenotype
CTD_human
Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21.
23839791
2014
×
Entrez Id:
284207
Gene Symbol:
METRNL
METRNL
0.300
Therapeutic
phenotype
CTD_human
Furthermore, METRNL administration rescued glucose intolerance and reduced HFD-induced body weight gain in mice; however, METRNL did not affect calorie intake.
30213948
2018
×
Entrez Id:
6319
Gene Symbol:
SCD
SCD
0.200
Therapeutic
phenotype
CTD_mouse
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.
21661758
2011
×
Entrez Id:
8701
Gene Symbol:
DNAH11
DNAH11
0.400
Biomarker
phenotype
CTD_human
Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice.
19030233
2008
×
Entrez Id:
3620
Gene Symbol:
IDO1
IDO1
0.300
Biomarker
phenotype
CTD_human
Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
27020609
2016
×
Entrez Id:
857
Gene Symbol:
CAV1
CAV1
0.300
Biomarker
phenotype
CTD_human
Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice.
19030233
2008
×
Entrez Id:
51449
Gene Symbol:
PCYOX1
PCYOX1
0.300
Biomarker
phenotype
CTD_human
Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice.
19030233
2008
×
Entrez Id:
586
Gene Symbol:
BCAT1
BCAT1
0.300
Biomarker
phenotype
CTD_human
Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice.
19030233
2008
×
Entrez Id:
4811
Gene Symbol:
NID1
NID1
0.300
Biomarker
phenotype
CTD_human
Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice.
19030233
2008
×
Entrez Id:
9518
Gene Symbol:
GDF15
GDF15
0.300
Biomarker
phenotype
CTD_human
Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice.
19030233
2008
×
Entrez Id:
6711
Gene Symbol:
SPTBN1
SPTBN1
0.300
Biomarker
phenotype
CTD_human
Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice.
19030233
2008